Publications

Author

Title

Year sorteringsordning

Fulltext

Widmark, Anders
Gunnlaugsson, A.
Beckman, L.; et al.

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial "HYPO-RT-PC"
International Journal of Radiation Oncology, Biology, Physics, 96(5): 938-939

2016

-

Nyqvist, Johanna
Fransson, Per
Laurell, Göran; et al.

Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer: A five year follow up
Radiotherapy and Oncology, 118(2): 335-341

2016

-

Zackrisson, Björn
Kjellén, Elisabeth
Söderström, Karin; et al.

Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial
Radiotherapy and Oncology, 117(1): 99-105

2015

-

Franzen, Lars
Sartor, O.
Parker, C.; et al.

Long-term safety and real world clinical experience of radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the phase 3 ALSYMPCA study
European Journal of Nuclear Medicine and Molecular Imaging, 41(suppl 2): S271-S271

2014

-

Parker, C.
Nilsson, S.
Heinrich, D.; et al.

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
New England Journal of Medicine, 369(3): 213-223

2013

-

Parker, C.
Heinrich, D.
Bottomley, D.; et al.

Effects of radium-223 dichloride (Ra-223) on health-related quality of life (QOL) outcomes in the phase 3 ALSYMPCA study in patients with castration-resistant prostate cancer (CRPC) and bone metastases
European Journal of Cancer, 49(Supplement 2): S689-S689, Meeting Abstract: 2878

2013

-

Nilsson, Sten
Franzén, Lars
Parker, Christopher; et al.

Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
Clinical Genitourinary Cancer, 11(1): 20-26

2013

-

Nilsson, S.
Strang, P.
Aksnes, A. K.; et al.

A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
European Journal of Cancer, 48(5): 678-686

2012

-

Zackrisson, Björn
Nilsson, Per
Kjellén, Elisabeth; et al.

Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN study
Radiotherapy and Oncology, 100(1): 41-48

2011

-

Daşu, Alexandru
Toma-Daşu, Iuliana
Franzén, Lars; et al.

Secondary malignancies from prostate cancer radiation treatment: a risk analysis of the influence of target margins and fractionation patterns
International Journal of Radiation Oncology, Biology, Physics, 79(3): 738-746

2011

-


Page Editor: Maria Wing

Print page